John Maraganore is a director of ProKidney Corp - Ordinary Shares.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kymera Therapeutics, Inc.
20 Jun 24
4
Beam Therapeutics Inc.
7 Jun 24
3
Rapport Therapeutics, Inc.
6 Jun 24
4
PROKIDNEY CORP.
3 Jul 23
4
Kymera Therapeutics, Inc.
20 Jun 23
4
Beam Therapeutics Inc.
8 Jun 23
5
AGIOS PHARMACEUTICALS, INC.
3 Feb 23
4
Beam Therapeutics Inc.
2 Sep 22
4
PROKIDNEY CORP.
13 Jul 22
3
PROKIDNEY CORP.
13 Jul 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jun 24 | KYMR Kymera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 31.2 | 16,000 | 499.20 k | 16,000 |
5 Jun 24 | BEAM Beam Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 24.49 | 23,114 | 566.06 k | 23,114 |
29 Jun 23 | PROK ProKidney Corp - Ordinary Shares | Director stock option Class A Ordinary Shares | Grant | Acquire A | No | No | 10.56 | 48,128 | 508.23 k | 48,128 |
15 Jun 23 | KYMR Kymera Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 27.67 | 12,000 | 332.04 k | 12,000 |